Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Precision BioSciences, Inc. (DTIL) had Return on Equity of -50.53% for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$34.26M |
|
$-45.72M |
|
-- |
|
$34.26M |
|
$86.41M |
|
$-52.15M |
|
$5.54M |
|
$-46.61M |
|
$-46.15M |
|
$-46.61M |
|
$-46.61M |
|
$-45.72M |
|
$-46.15M |
|
$-52.15M |
|
$-50.08M |
|
12.83M |
|
12.83M |
|
$-3.56 |
|
$-3.56 |
|
| Balance Sheet Financials | |
$118.74M |
|
$1.43M |
|
$35.68M |
|
$154.42M |
|
$8.91M |
|
$22.40M |
|
$53.26M |
|
$62.17M |
|
$92.25M |
|
$91.08M |
|
$92.25M |
|
24.09M |
|
| Cash Flow Statement Financials | |
$-65.84M |
|
$-0.63M |
|
$95.16M |
|
$108.47M |
|
$137.15M |
|
$28.68M |
|
$10.19M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
13.32 |
|
-- |
|
-- |
|
0.20 |
|
0.24 |
|
100.00% |
|
-152.19% |
|
-152.19% |
|
-146.15% |
|
-136.03% |
|
-133.45% |
|
$-65.86M |
|
-- |
|
-- |
|
-- |
|
0.22 |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
-50.53% |
-51.17% |
|
-30.18% |
|
-40.65% |
|
$3.83 |
|
$-5.13 |
|
$-5.13 |
|